Imatinib TDM in GIST
Condition(s):Gastrointestinal Stromal TumorsLast Updated:January 12, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Gastrointestinal Stromal TumorsLast Updated:January 12, 2024Not yet recruiting
Condition(s):Metastatic Gastrointestinal Stromal Tumor (GIST); C-KIT Mutation; Advanced Gastrointestinal Stromal Tumor (GIST)Last Updated:September 1, 2023Recruiting
Condition(s):Gastrointestinal Stromal Tumor of RectumLast Updated:August 1, 2023Not yet recruiting
Condition(s):Papillary Thyroid CancerLast Updated:February 2, 2023Recruiting
Condition(s):Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, BCR/ABL-Positive; Chronic Myeloid Leukemia in RemissionLast Updated:October 23, 2023Recruiting
Condition(s):Head and Neck Cancer; Squamous Cell Carcinoma of Head and NeckLast Updated:March 8, 2024Recruiting
Condition(s):Progression-free Survival; Gastrointestinal Stromal Tumor; NeoadjuvantLast Updated:October 12, 2021Recruiting
Condition(s):DermoidLast Updated:January 23, 2024Recruiting
Condition(s):Inherited Bone Marrow Failure Syndrome; Familial Platelet Disorder With Predisposition to Myeloid MalignanciesLast Updated:January 5, 2024Recruiting
Condition(s):Gastrointestinal Stromal TumorsLast Updated:March 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.